All Stories

  1. Metabolic Reprogramming and Tunneling Nanotubes Cooperate to Regulate HIV-1 Latency Reactivation
  2. Profiling of Extracellular Vesicles of Non‐Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance
  3. Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting
  4. Toward a Species Search Engine: KISSE Offers a Rigorous Statistical Framework for Bone Collagen Tandem Mass Spectrometry Data
  5. Changes in circulating extracellular vesicle cargo are associated with cognitive decline after major surgery: an observational case–control study
  6. The Temporal Dynamics of Proteins in Aged Skin Wound Healing and Comparison with Gene Expression
  7. Comprehensive analysis of multi‐omics single‐cell data using the single‐cell analyst
  8. Collaborative Duality of CircGLIS3(2) RNA and Protein in human Wound Repair
  9. Tissue-specific responses to TFAM and mtDNA copy number manipulation in prematurely ageing mice
  10. Tissue-specific responses to TFAM and mtDNA copy number manipulation in prematurely ageing mice
  11. The proteome of osteoblasts in a 3D culture perfusion bioreactor model compared with static conditions
  12. Towards a species search engine: KISSE offers a rigorous statistical framework for bone collagen tandem mass spectrometry data
  13. Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes
  14. Acute high-dose irradiation of human primary ovarian cells reveals a shift in transcriptomics profile and impairment in cell-cell adhesion
  15. Proteomic analysis reveals biomarkers associated with performance-based joint function and patient-reported outcomes in knee osteoarthritis
  16. Host Plasma Microenvironment in Immunometabolically Impaired HIV Infection Leads to Dysregulated Monocyte Function and Synaptic Transmission Ex Vivo
  17. Tissue-specific responses to TFAM and mtDNA copy number manipulation in prematurely ageing mice
  18. The di-leucine motif in the host defense peptide LL-37 is essential for initiation of autophagy in human macrophages
  19. Silk-Ovarioids: establishment and characterization of a human ovarian primary cell 3D-model system
  20. SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model
  21. Characterization of the HLA-DR immunopeptidome of bronchoalveolar lavage cells in patients with newly diagnosed rheumatoid arthritis and healthy current-smoker controls
  22. Tissue-specific responses to TFAM and mtDNA copy number manipulation in prematurely ageing mice
  23. microRNA and non-targeted proteome analysis of liquid biopsies from the distal lung collected by Particles in Exhaled Air (PExA) reveals presence from extracellular vesicles
  24. Bacterial extracellular vesicles as intranasal postbiotics: Detailed characterization and interaction with airway cells
  25. Mouse PAW: reverse-translating the FINGER multimodal lifestyle intervention enhances synaptic plasticity and cognition in adult wild type female mice
  26. Gel-Assisted Proteome Position Integral Shift Assay Returns Molecular Weight to Shotgun Proteomics and Identifies Caspase 3 Substrates
  27. Silk-Ovarioids: Establishment and characterization of human ovarian primary cells 3D-model system
  28. Network analysis reveals age‐ and virus‐specific circuits in nasal epithelial cells of extremely premature infants
  29. A multi-platform analysis of human gingival crevicular fluid reveals ferroptosis as a relevant regulated cell death mechanism during the clinical progression of periodontitis
  30. Abstract 5138: Proteomic analyses of the urothelial cancer landscape reveal highly distinct prognostic and predictive subtypes
  31. TISSUE-SPECIFIC METABOLOMIC REPROGRAMMING DETERMINES THE DISEASE PATHOPHYSIOLOGY OF SARS-COV-2 VARIANTS IN HAMSTER MODEL
  32. Gel-Assisted Proteome Position Integral Shift (GAPPIS) Assay Returns Molecular Weight to Shotgun Proteomics and Identifies Novel Caspase 3 Substrates
  33. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation
  34. Toward Single Bacterium Proteomics
  35. Multifaceted proteome analysis at solubility, redox, and expression dimensions for target identification
  36. Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies
  37. Proteomic profile of human gingival crevicular fluid reveals specific biological and molecular processes during clinical progression of periodontitis
  38. Non-typeable Haemophilus influenzae major outer membrane protein P5 contributes to bacterial membrane stability, and affects the membrane protein composition crucial for interactions with the human host
  39. Distribution, cellular localization, and colocalization of several peptide neurotransmitters in the central nervous system ofAplysia
  40. Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism
  41. NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions
  42. Genomic adaptation underlies nutrient-driven reprogramming in the malaria-causing parasite
  43. Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism
  44. Panomics reveals patient individuality as the major driver of colorectal cancer progression
  45. Impaired Immuno-Metabolic Homeostasis and Microenvironmental Influence on Neuropsychiatric Risk in Treated HIV Infection
  46. Brain endothelial cells exposure to malaria parasites links Type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption and cell metabolic adaptation
  47. Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways
  48. Panomics reveals patient-individuality as the major driver for colorectal cancer progression
  49. Mapping the GALNT1 substrate landscape with versatile proteomics tools
  50. Single-Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  51. Mass Spectrometry, Structural Analysis, and Anti-Inflammatory Properties of Photo-Cross-Linked Human Albumin Hydrogels
  52. Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids
  53. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
  54. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
  55. Epigenetic modulators link mitochondrial redox homeostasis to cardiac function
  56. Author response: Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
  57. Nucleoside-Modified mRNA Vaccines Protect IFNAR –/– Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
  58. Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
  59. Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
  60. Mass Spectrometry-Based Analytical Strategy for Single-Cell Proteomics
  61. Ultralight ultrafast enzymes
  62. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
  63. Single Cell Proteomics Using Multiplexed Isobaric Labeling for Mass Spectrometric Analysis
  64. Citrullination Alters the Antibacterial and Anti-Inflammatory Functions of the Host Defense Peptide Canine Cathelicidin K9CATH In Vitro
  65. Trans Cohorts Metabolomic Modulation Following Long-Term Successful Therapy in HIV-Infection
  66. Coordinated pyruvate kinase activity is crucial for metabolic adaptation and cell survival during mitochondrial dysfunction
  67. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
  68. Longitudinal blood cell transcriptomic profiling and in vitro temporal proteomics provides novel insights into metabolic reprogramming and host-immune responses against Crimean-Congo Hemorrhagic Fever Virus
  69. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
  70. Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  71. Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
  72. EPHA2 Interacts with DNA-PKcs in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
  73. System-wide identification and prioritization of enzyme substrates by thermal analysis
  74. The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters
  75. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
  76. Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
  77. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo Hemorrhagic Fever Viruses for novel therapeutic target
  78. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
  79. Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
  80. Correction: S100A6 is a critical regulator of hematopoietic stem cells
  81. S100A6 is a critical regulator of hematopoietic stem cells
  82. Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
  83. Studies on citrullinated LL-37: detection in human airways, antibacterial effects and biophysical properties
  84. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
  85. ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
  86. Current status of clinical proteogenomics in lung cancer
  87. Malondialdehyde Conjugated With Albumin Induces Pro-Inflammatory Activation of T Cells Isolated From Human Atherosclerotic Plaques Both Directly and Via Dendritic Cell–Mediated Mechanism
  88. System-wide identification and prioritization of enzyme substrates by thermal analysis (SIESTA)
  89. ProTargetMiner: A proteome signature library of anticancer molecules for functional discovery
  90. Deuteration of human carbonic anhydrase for neutron crystallography: Cell culture media, protein thermostability, and crystallization behavior
  91. Large Scale Identification of Variant Proteins in Glioma Stem Cells
  92. In vivo Distribution of Tiotropium in a Rodent Model Utilizing AP-SMALDI Mass Spectrometry Imaging
  93. Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors
  94. Relationship between HMF intake and SMF formation in vivo: An animal and human study
  95. Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
  96. Novel insights in drug metabolism by MS imaging
  97. Mutant Proteogenomics
  98. Proteogenomics
  99. Drug localizations in tissue by mass spectrometry imaging
  100. In Vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins
  101. Drug compound characterization by mass spectrometry imaging in cancer tissue
  102. Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project
  103. Erratum to: Association of chromosome 19 to lung cancer genotypes and phenotypes
  104. Association of chromosome 19 to lung cancer genotypes and phenotypes
  105. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study
  106. Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging
  107. Use of ENCODE Resources to Characterize Novel Proteoforms and Missing Proteins in the Human Proteome
  108. Systematic Identification of Single Amino Acid Variants in Glioma Stem-Cell-Derived Chromosome 19 Proteins
  109. SC-23 * THE ROLE OF SINGLE AMINO ACID POLYMORPHISMS IN GLIOMA STEM CELL PHENOTYPES
  110. A new look at drugs targeting malignant melanoma-An application for mass spectrometry imaging
  111. Aptamer/ISET-MS: A New Affinity-Based MALDI Technique for Improved Detection of Biomarkers
  112. Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development
  113. Queries of MALDI-imaging global datasets identifying ion mass signatures associated with tissue compartments
  114. Identification of Missing Proteins: Toward the Completion of Human Proteome
  115. Integrated Chromosome 19 Transcriptomic and Proteomic Data Sets Derived from Glioma Cancer Stem-Cell Lines
  116. Developments in biobanking workflow standardization providing sample integrity and stability
  117. Experimental Models to Study Drug Distributions in Tissue Using MALDI Mass Spectrometry Imaging
  118. Accessing microenvironment compartments in formalin-fixed paraffin-embedded tissues by protein expression analysis
  119. Quantification of Human Kallikrein-2 in Clinical Samples by Selected Reaction Monitoring
  120. Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring
  121. Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction
  122. Blood Plasma Reference Material: A Global Resource for Proteomic Research
  123. Correlation Queries for Mass Spectrometry Imaging
  124. Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
  125. International biobanking for lung cancer and COPD as the future resource for clinical protein research
  126. Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage
  127. A Critical Evaluation of Inflammatory Markers in Huntington's Disease Plasma
  128. Clinical and Biomedical Mass Spectrometry: New Frontiers in Drug Developments and Diagnosis
  129. Chromosome 19 Annotations with Disease Speciation: A First Report from the Global Research Consortium
  130. Large scale biobanking of blood — The importance of high density sample processing procedures
  131. Standardization and Utilization of Biobank Resources in Clinical Protein Science with Examples of Emerging Applications
  132. Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry
  133. Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care
  134. Clinical Proteomics
  135. Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
  136. Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples
  137. MRM assay for quantitation of complement components in human blood plasma — a feasibility study on multiple sclerosis
  138. State-of-the-art MS technology applications in lung disease
  139. Direct Demonstration of Tissue Uptake of an Inhaled Drug: Proof-of-Principle Study Using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging
  140. Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging
  141. Biobank resources for future patient care: developments, principles and concepts
  142. Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
  143. Clinical Protein Science and Bioanalytical Mass Spectrometry with an Emphasis on Lung Cancer
  144. Essential tactics of tissue preparation and matrix nano-spotting for successful compound imaging mass spectrometry
  145. Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
  146. Isotope labeled internal standards (ILIS) as a basis for quality control in clinical studies using plasma samples
  147. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
  148. Determination of dissociation constants between polyelectrolytes and proteins by affinity capillary electrophoresis
  149. Identification of novel candidate protein biomarkers for the post-polio syndrome — Implications for diagnosis, neurodegeneration and neuroinflammation
  150. General Approach for Certain Quantitative Calculations for Instance of the Variance of Reversible Adsorption to the Capillary Wall in CE
  151. Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology
  152. Activity of the Small Modified Amino Acid α-Hydroxy Glycineamide on In Vitro and In Vivo Human Immunodeficiency Virus Type 1 Capsid Assembly and Infectivity
  153. Implementation of a protein profiling platform developed as an academic‐pharmaceutical industry collaborative effort
  154. Universal method for synthesis of artificial gel antibodies by the imprinting approach combined with a unique electrophoresis technique for detection of minute structural differences of proteins, viruses and cells (bacteria). Ib. Gel antibodies against...
  155. Universal method for synthesis of artificial gel antibodies by the imprinting approach combined with a unique electrophoresis technique for detection of minute structural differences of proteins, viruses, and cells (bacteria). III: Gel antibodies again...
  156. Theoretical and nomenclatural considerations of capillary electrochromatography with monolithic stationary phases
  157. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis
  158. Homogeneous gels for capillary electrochromatography
  159. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis
  160. Chapter 10 Technologies interfacing capillary electrophoresis to mass spectrometry
  161. Chapter 3 Peptide and protein separations by capillary electrophoresis and electrochromatography
  162. 2 Evolution and development of isoelectric focusing
  163. Hybrid microdevice electrophoresis of peptides, proteins, DNA, viruses, and bacteria in various separation media, using UV-detection
  164. High-Resolution Capillary Zone and Gel Electrophoresis of Structurally Similar Amphipathic Glutathione Conjugates Based on Interaction with -Cyclodextrins
  165. Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis
  166. A hybrid microdevice for electrophoresis and electrochromatography using UV detection
  167. Stable homogeneous gel for molecular-sieving of DNA fragments in capillary electrophoresis
  168. Enantioseparation of hydroxy acids on easy-to-prepare continuous beds for capillary electrochromatography
  169. Chiral separation of amino acids by ligand-exchange capillary electrochromatography using continuous beds
  170. A new easy-to-prepare homogeneous continuous electrochromatographic bed for enantiomer recognition
  171. A new easy-to-prepare homogeneous continuous electrochromatographic bed for enantiomer recognition
  172. Chiral separation of amino acids by ligand-exchange capillary electrochromatography using continuous beds
  173. (Normal-phase) capillary chromatography using acrylic polymer-based continuous beds
  174. Chiral separation of α-amino acids by ligand-exchange capillary electrophoresis usingN-(2-hydroxy-octyl)-L-4-hydroxyproline as a selector
  175. New set-up for capillary isoelectric focusing in uncoated capillaries